fda glp-1 compounding crackdown news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA cracks down on 'misleading'

Emerging evidence suggests that dual GLP-1/GIP agonists like tirzepatide may offer a more favorable gastrointestinal profile in some patients, potentially improving adherence (Kim et al., 2025)

The sequence corresponds to a fragment originally identified within a larger protein derived from gastric tissue, and it is studied as an isolated peptide with consistent physicochemical characteristics

Glutathione is a naturally occurring antioxidant found throughout the body and is involved in protecting cells from oxidative stress while supporting normal cellular functions

In addition to serving as the main store of energy, it is well-known for its endocrine activity 111,112

Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity

J Physiol Pharmacol , 60(Suppl 7), 191-96